# TNF Pharmaceuticals, Inc. — Form D

TNF Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-08-11. Industry: Other Health Care.

## Offering

- Filed: 2020-08-11
- Form: D
- Accession: 0001493152-20-015232
- Industry: Other Health Care
- Exemptions: 06b
- Investors: 1
- Date of first sale: 2020-08-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-372987

## Issuer

- Name: TNF Pharmaceuticals, Inc.
- CIK: 0001321834
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 1185 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036
- Phone: 856-848-8698

## Officers, directors & promoters (30)

_Showing 25 of 30 people._

| Name | Role | Location |
| --- | --- | --- |
| Howard Yeaton | Executive Officer | Thorofare, NJ |
| Joshua Silverman | Director | NEW YORK, NY |
| Joshua Silverman | Executive Officer | NEW YORK, NY |
| BRUCE BERNSTEIN | Director | Miami, FL |
| Christopher Schreiber | Director | New York, NY |
| Ian Rhodes | Executive Officer | New York, NY |
| Mitchell J Glass | Director | New York, NY |
| Mitchell J Glass | Executive Officer | New York, NY |
| Stephen J Friscia | Director | New York, NY |
| Bill J White | Director | New York, NY |
| Bill White | Director | San Jose, CA |
| Chris Chapman | Director | BALTIMORE, MD |
| Chris Chapman | Executive Officer | BALTIMORE, MD |
| Jude Uzonwanne | Director | BALTIMORE, MD |
| Craig Eagle | Director | Grasonville, MD |
| Thomas Knox | Director | Baltimore, MD |
| Paul Rivard | Executive Officer | Baltimore, MD |
| Adam Kaplin | Executive Officer | Baltimore, MD |
| Joshua C Silverman | Director | Round Rock, TX |
| Stuart Benson | Executive Officer | Thorofare, NJ |
| Christopher C Schreiber | Director | Thorofare, NJ |
| Christopher C Schreiber | Executive Officer | Thorofare, NJ |
| Raymond Akers | Director | THOROFARE, NJ |
| Raymond Akers | Executive Officer | THOROFARE, NJ |
| Brandon Knox | Director | THOROFARE, NJ |

## Other filings by this issuer (9)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-09-05](https://search.stillhousedata.com/formd/0001641172-25-026761) | D | $7.0M | $7.0M |
| [2024-05-31](https://search.stillhousedata.com/formd/0001493152-24-022083) | D | $15.2M | $15.2M |
| [2024-05-31](https://search.stillhousedata.com/formd/0001493152-24-022082) | D | $26.9M | $26.9M |
| [2022-08-30](https://search.stillhousedata.com/formd/0001493152-22-024345) | D | $7.4M | — |
| [2020-11-24](https://search.stillhousedata.com/formd/0001493152-20-022415) | D | $18.1M | $18.1M |
| [2020-05-21](https://search.stillhousedata.com/formd/0001493152-20-009612) | D | $482K | $482K |
| [2020-04-14](https://search.stillhousedata.com/formd/0001493152-20-006344) | D | $460K | $460K |
| [2020-04-07](https://search.stillhousedata.com/formd/0001493152-20-006006) | D | $2.7M | $1.2M |
| [2017-04-13](https://search.stillhousedata.com/formd/0001493152-17-003835) | D | $2.0M | $2.0M |

## More

- [CIK 1321834 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1321834&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001493152-20-015232.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.